Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.57 |
| ▸ | FAAH | O00519 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.49 |
| ▸ | PAFAH1B2 | P68402 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9660268 | 1.00 | LPAR3 (0.59) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL9659826 | 0.96 | LPAR3 (0.62) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL9659819 | 0.96 | LPAR3 (0.62) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL2184672 | 0.96 | LPAR3 (0.62) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL2184674 | 0.96 | LPAR3 (0.62) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL30906162 | 0.95 | ALDH1A1 (0.56) | LPAR3LPAR2LPAR1FAAHMEN1 | |
| SCHEMBL8924586 | 0.89 | CYP3A4 (0.56) | LPAR3LPAR2LPAR1FAAHCYP3A4 | |
| SCHEMBL11636666 | 0.89 | CYP3A4 (0.56) | LPAR3LPAR2LPAR1FAAHCYP3A4 | |
| SCHEMBL3981117 | 0.89 | CYP3A4 (0.56) | LPAR3LPAR2LPAR1FAAHCYP3A4 | |
| SCHEMBL9660441 | 0.89 | CYP3A4 (0.56) | LPAR3LPAR2LPAR1FAAHCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | EKTAH (FR) | 2021-08-05 | — | — | US | disclosed |
| EP-0510633-A1 | Lubricating oil composition and use thereof | JAPAN SUN OIL COMPANY, LTD. (JP) | 1992-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238209-A1 | OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES | FFAR3, FFAR2, FFAR1 | LPAR3 19/4885LPAR2 33/4885LPAR1 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.